Skip to main navigation Skip to search Skip to main content

Regulator of G-Protein Signaling-4 Attenuates Cardiac Adverse Remodeling and Neuronal Norepinephrine Release-Promoting Free Fatty Acid Receptor FFAR3 Signaling

  • Alexandra M. Carbone
  • , Jordana I. Borges
  • , Malka S. Suster
  • , Anastasiya Sizova
  • , Natalie Cora
  • , Victoria L. Desimine
  • , Anastasios Lymperopoulos

Research output: Contribution to journalArticlepeer-review

Abstract

Propionic acid is a cell nutrient but also a stimulus for cellular signaling. Free fatty acid receptor (FFAR)-3, also known as GPR41, is a Gi/o protein-coupled receptor (GPCR) that mediates some of the propionate’s actions in cells, such as inflammation, fibrosis, and increased firing/norepinephrine release from peripheral sympathetic neurons. The regulator of G-protein Signaling (RGS)-4 inactivates (terminates) both Gi/o-and Gq-protein signaling and, in the heart, protects against atrial fibrillation via calcium signaling attenuation. RGS4 activity is stimulated by β-adrenergic receptors (ARs) via protein kinase A (PKA)-dependent phosphorylation. Herein, we examined whether RGS4 modulates cardiac FFAR3 signaling/function. We report that RGS4 is essential for dampening of FFAR3 signaling in H9c2 cardiomyocytes, since siRNA-mediated RGS4 depletion significantly enhanced propionate-dependent cAMP lowering, Gi/o activation, p38 MAPK activation, pro-inflammatory interleukin (IL)-1β and IL-6 production, and pro-fibrotic transform-ing growth factor (TGF)-β synthesis. Additionally, catecholamine pretreatment blocked propionic acid/FFAR3 signaling via PKA-dependent activation of RGS4 in H9c2 cardiomyocytes. Finally, RGS4 opposes FFAR3-dependent norepinephrine release from sympathetic-like neurons (differentiated Neuro-2a cells) co-cultured with H9c2 cardiomyocytes, thereby preserving the functional βAR number of the cardiomyocytes. In conclusion, RGS4 appears essential for propionate/FFAR3 signaling attenuation in both cardiomyocytes and sympathetic neurons, leading to cardioprotection against inflammation/adverse remodeling and to sympatholysis, respectively.
Original languageEnglish
Article number5803
JournalInternational Journal of Molecular Sciences
Volume23
Issue number10
DOIs
StatePublished - May 22 2022

Bibliographical note

Publisher Copyright:
© 2022 by the authors. Licensee MDPI, Basel, Switzerland.

Funding

This research was funded by an NIH/NHLBI (R01 #HL155718-01) grant and an NSU‘s President‘s Faculty Research & Development Grant (PFRDG award) (both to A.L.).

ASJC Scopus Subject Areas

  • Catalysis
  • Molecular Biology
  • Spectroscopy
  • Computer Science Applications
  • Physical and Theoretical Chemistry
  • Organic Chemistry
  • Inorganic Chemistry

Keywords

  • cardiomy-ocyte
  • catecholamine
  • FFAR3
  • G-protein-coupled receptor
  • inflammation
  • norepinephrine
  • propionic acid
  • RGS4
  • signal transduction
  • sympathetic neuron
  • RGS Proteins/genetics
  • Humans
  • Inflammation/metabolism
  • Propionates/metabolism
  • Fatty Acids, Nonesterified/metabolism
  • Norepinephrine/metabolism
  • GTP-Binding Protein alpha Subunits, Gq-G11/metabolism
  • Neurons/metabolism
  • Receptors, G-Protein-Coupled/metabolism
  • Calcium Signaling

Disciplines

  • Catalysis and Reaction Engineering
  • Molecular Biology
  • Computer Sciences
  • Physical Chemistry
  • Inorganic Chemistry
  • Organic Chemistry

Fingerprint

Dive into the research topics of 'Regulator of G-Protein Signaling-4 Attenuates Cardiac Adverse Remodeling and Neuronal Norepinephrine Release-Promoting Free Fatty Acid Receptor FFAR3 Signaling'. Together they form a unique fingerprint.

Cite this